Financials
- Market Capitalization 263.9 M
- Employee 44
- Founded 2015
- CEO N/A
- Website www.surrozen.com
- Headquarter Delaware, United States
- FIGI BBG00XY94S95
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.7
市销率
0.05
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3407 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.09 USD | +6.63% | -1.42% | +22.94% | +7.73% | 275.95 M USD | ||
| 3410 | GLSI Greenwich LifeSciences, Inc. - Common stock | 18.74 USD | +0.92% | -8.14% | -23.26% | +75.30% | 275.07 M USD | ||
| 3434 | NAGE Niagen Bioscience, Inc. - Common Stock | 3.31 USD | -4.61% | -7.28% | -4.89% | -33.53% | 263.62 M USD | ||
| 3447 | ALXO ALX Oncology Holdings Inc. - Common Stock | 1.93 USD | -2.03% | -18.57% | +21.38% | +319.57% | 259.71 M USD |